Dupont Capital Management Corp Organogenesis Holdings Inc. Transaction History

Dupont Capital Management Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$2.48 - $3.43 $6,862 - $9,490	-2,767 Reduced 9.68%	25,819 $0
Q3 2022 Oct 31, 2022	BUY	$3.14 - $6.43 $25,578 - $52,378	8,146 Added 39.85%	28,586 $93,000
Q1 2022 Apr 27, 2022	SELL	$6.47 - $9.57 $11,697 - $17,302	-1,808 Reduced 8.13%	20,440 $156,000
Q4 2021 Jan 31, 2022	BUY	$9.02 - $13.5 $42,935 - $64,260	4,760 Added 27.22%	22,248 $206,000
Q3 2021 Nov 03, 2021	SELL	$13.71 - $17.18 $33,904 - $42,486	-2,473 Reduced 12.39%	17,488 $249,000
Q2 2021 Jul 30, 2021	BUY	$14.92 - $23.23 $297,818 - $463,694	19,961 New	19,961 $332,000

118

64.3M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $462M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.